Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,995 public trials 1,209 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies

NCT04349436

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Cancer, +23 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California, San Diego La Jolla, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NCT05352672

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations
  • UC San Diego La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Seidman Cancer Center Cleveland, Ohio, United States
View all 210 locations
View Trial Details
Active, Not Recruiting

A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence

NCT06336291

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

NCT04106219

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • University of Chicago - Comer Children's Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 17 locations
View Trial Details

Related conditions